ClinicalTrials.gov
ClinicalTrials.gov Menu

WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01827137
Recruitment Status : Active, not recruiting
First Posted : April 9, 2013
Last Update Posted : February 10, 2017
Sponsor:
Collaborator:
IND transferred to Sellas
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : April 2018
  Estimated Study Completion Date : April 2018